Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Neuro-Hitech Inc.

www.neurohitech.com

Latest From Neuro-Hitech Inc.

Market Insight - Rich pickings from reformulations?

In recent years, drug reformulation has emerged as a popular defence strategy among pharmaceutical companies seeking to prolong the life cycles of their best-selling products. It has also attracted growing interest from specialist companies developing novel formulations of off-patent drugs and which either launch them as replacements for the originator products, or reposition them for new indications.

Gastrointestinal Metabolic Disorders
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
      • Transdermal
    • Nutraceuticals
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Neuro-Hitech Pharmaceuticals Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Neuro-Hitech Inc.
  • Senior Management
  • Matt Colpoys, Pres. & CEO
    David Barrett, CFO
    William Wong, PhD, CSO
  • Contact Info
  • Neuro-Hitech Inc.
    Phone: (212) 594-1215
    One Penn Plaza
    Ste. 1503
    New York, NY 10019
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register